Free Trial

Codexis (CDXS) News Today

Codexis logo
$2.52 +0.20 (+8.62%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$2.52 +0.00 (+0.20%)
As of 05/2/2025 06:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Codexis, Inc. stock logo
Nantahala Capital Management LLC Sells 126,148 Shares of Codexis, Inc. (NASDAQ:CDXS)
Nantahala Capital Management LLC reduced its stake in Codexis, Inc. (NASDAQ:CDXS - Free Report) by 4.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,841,660 shares of the biotechnology company's stock after s
Codexis, Inc. stock logo
Envestnet Asset Management Inc. Purchases 110,541 Shares of Codexis, Inc. (NASDAQ:CDXS)
Envestnet Asset Management Inc. increased its stake in Codexis, Inc. (NASDAQ:CDXS - Free Report) by 55.5% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 309,713 shares of the biotechnology company's stock after buying an add
Codexis, Inc. stock logo
Codexis, Inc. (NASDAQ:CDXS) Shares Bought by JPMorgan Chase & Co.
JPMorgan Chase & Co. raised its position in Codexis, Inc. (NASDAQ:CDXS - Free Report) by 484.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 183,906 shares of the biotechnology company's s
Codexis (CDXS) Projected to Post Quarterly Earnings on Thursday
Codexis, Inc. stock logo
Geode Capital Management LLC Boosts Stock Position in Codexis, Inc. (NASDAQ:CDXS)
Geode Capital Management LLC raised its holdings in Codexis, Inc. (NASDAQ:CDXS - Free Report) by 12.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,855,514 shares of the
Codexis, Inc. stock logo
Codexis (CDXS) Projected to Post Earnings on Thursday
Codexis (NASDAQ:CDXS) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 1. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-1-codexis-inc-stock/)
Codexis, Inc. stock logo
182,223 Shares in Codexis, Inc. (NASDAQ:CDXS) Acquired by EAM Investors LLC
EAM Investors LLC bought a new position in shares of Codexis, Inc. (NASDAQ:CDXS - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 182,223 shares of the biotechnology company's stock, valu
Codexis, Inc. stock logo
Franklin Resources Inc. Increases Position in Codexis, Inc. (NASDAQ:CDXS)
Franklin Resources Inc. boosted its holdings in Codexis, Inc. (NASDAQ:CDXS - Free Report) by 501.2% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 177,101 shares of the biotechnology company's stock after purchasing an additional 147,645 shares duri
Codexis, Inc. stock logo
Vanguard Group Inc. Purchases 311,082 Shares of Codexis, Inc. (NASDAQ:CDXS)
Vanguard Group Inc. boosted its position in Codexis, Inc. (NASDAQ:CDXS - Free Report) by 7.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,463,801 shares of the biotechnology company's
Codexis, Inc. stock logo
CenterBook Partners LP Makes New $4.69 Million Investment in Codexis, Inc. (NASDAQ:CDXS)
CenterBook Partners LP purchased a new position in shares of Codexis, Inc. (NASDAQ:CDXS - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 982,848 shares of the biotechnology company's stock, valued at ap
Codexis appoints new independent board member
Codexis appoints new independent board member
Codexis, Inc. stock logo
Codexis, Inc. (NASDAQ:CDXS) Short Interest Up 50.8% in March
Codexis, Inc. (NASDAQ:CDXS - Get Free Report) was the target of a large increase in short interest in March. As of March 15th, there was short interest totalling 4,570,000 shares, an increase of 50.8% from the February 28th total of 3,030,000 shares. Based on an average daily trading volume, of 843,500 shares, the short-interest ratio is currently 5.4 days. Currently, 5.7% of the shares of the stock are sold short.
Codexis, Inc. stock logo
FY2025 EPS Estimates for Codexis Cut by Cantor Fitzgerald
Codexis, Inc. (NASDAQ:CDXS - Free Report) - Equities researchers at Cantor Fitzgerald decreased their FY2025 earnings per share estimates for Codexis in a report released on Monday, March 10th. Cantor Fitzgerald analyst K. Kluska now anticipates that the biotechnology company will earn ($0.60) pe
Codexis, Inc. stock logo
Codexis, Inc. (NASDAQ:CDXS) Stock Holdings Lifted by Telemark Asset Management LLC
Telemark Asset Management LLC lifted its holdings in Codexis, Inc. (NASDAQ:CDXS - Free Report) by 11.3% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 3,000,000 shares of the biotechnology company's stock after buying an additional 303,589
Cantor Fitzgerald Sticks to Their Buy Rating for Codexis (CDXS)
Codexis Announces New Employment Inducement Grants
Codexis, Inc. stock logo
Cantor Fitzgerald Lifts Earnings Estimates for Codexis
Codexis, Inc. (NASDAQ:CDXS - Free Report) - Analysts at Cantor Fitzgerald upped their FY2025 earnings per share (EPS) estimates for Codexis in a research report issued on Tuesday, March 4th. Cantor Fitzgerald analyst K. Kluska now anticipates that the biotechnology company will post earnings per
Codexis, Inc. stock logo
Codexis (NASDAQ:CDXS) Releases Earnings Results, Misses Expectations By $0.09 EPS
Codexis (NASDAQ:CDXS - Get Free Report) posted its earnings results on Thursday. The biotechnology company reported ($0.13) earnings per share for the quarter, missing analysts' consensus estimates of ($0.04) by ($0.09). Codexis had a negative net margin of 96.35% and a negative return on equity of 71.56%.
Stifel Nicolaus Sticks to Their Buy Rating for Codexis (CDXS)
Q4 2024 Codexis Inc Earnings Call Transcript
Codexis, Inc. (CDXS) Q4 2024 Earnings Call Transcript
Codexis sees FY25 revenue $64M-$68M, consensus $66.61M
Craig-Hallum Sticks to Its Buy Rating for Codexis (CDXS)
Codexis, Inc. stock logo
Codexis (NASDAQ:CDXS) Stock Passes Above 200 Day Moving Average - Here's Why
Codexis (NASDAQ:CDXS) Stock Price Crosses Above 200-Day Moving Average - Here's What Happened
Codexis, Inc. stock logo
Codexis (CDXS) to Release Quarterly Earnings on Wednesday
Codexis (NASDAQ:CDXS) will be releasing earnings after the market closes on Wednesday, February 26. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=666462)
Codexis to Participate in TD Cowen 45th Annual Health Care Conference
Codexis, Inc. stock logo
Baillie Gifford & Co. Sells 119,775 Shares of Codexis, Inc. (NASDAQ:CDXS)
Baillie Gifford & Co. trimmed its holdings in shares of Codexis, Inc. (NASDAQ:CDXS - Free Report) by 6.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,694,025 shares of the biotechnology
Codexis Announces New Employment Inducement Grants
Get Codexis News Delivered to You Automatically

Sign up to receive the latest news and ratings for CDXS and its competitors with MarketBeat's FREE daily newsletter.

CDXS Media Mentions By Week

CDXS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CDXS
News Sentiment

0.98

0.81

Average
Medical
News Sentiment

CDXS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CDXS Articles
This Week

7

3

CDXS Articles
Average Week

Get Codexis News Delivered to You Automatically

Sign up to receive the latest news and ratings for CDXS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:CDXS) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners